Abstract P1-13-13: First planned efficacy analysis of the NNBC 3-Europe trial: Addition of docetaxel to anthracycline containing adjuvant chemotherapy in high risk node-negative breast cancer patients.
暂无分享,去创建一个
C. Meisner | N. Harbeck | C. Thomssen | V. Hanf | M. Vetter | D. Paepke | M. Schmitt | G. Minckwitz | F. Sweep | P. Martin | C. Veyret | E. Kantelhardt | F. Jaenicke | D. Augustin | G. Hoffmann | M. Schmidt | W. Wiest | W. Meinerz